Price Alert

ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · Real-Time Price · USD

2.04

0.02 (0.99%)

At close: Aug 15, 2025, 3:59 PM

2.05

0.24%

After-hours: Aug 15, 2025, 04:10 PM EDT

ProQR Therapeutics Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	132.41M	149.41M	89.4M	78.97M	85.79M	119.02M	120.55M	128.56M	138.99M	94.78M	100.43M	156.4M	167.61M	187.52M	156.14M	139.44M	67.88M
Short-Term Investments	n/a	n/a	n/a	17.19M	17.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	621K	621K	621K	621K	621K	621K	629K	713K	845K	621K
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	2.76M	2.03M	1.3M	4.55M	3.15M	1.27M	3.17M	400K	457K	57.24M	570K	498K	812K	555K	511K	381K	454K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	-1.52K	-521	-5.28K	6.87K	n/a	n/a	n/a	268K	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.19M	n/a	n/a	n/a	n/a	n/a	-3.96M	n/a	n/a	n/a
Total Current Assets	138.08M	153.84M	92.41M	101.83M	107.25M	121.09M	124.69M	131.15M	141.61M	154.46M	104.11M	161.06M	172.47M	191.48M	177.06M	143.58M	72.87M
Property-Plant & Equipment	13.61M	14.11M	14.44M	16.29M	16.74M	16.91M	17.35M	16.22M	15.78M	16.24M	17.01M	17.37M	17.14M	17.47M	17.56M	17.93M	18.12M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.61M	14.11M	14.44M	16.29M	16.74M	16.91M	17.35M	16.84M	16.4M	16.86M	17.63M	17.99M	17.76M	18.1M	18.27M	18.77M	18.74M
Total Assets	151.69M	167.96M	106.85M	118.12M	123.99M	138M	142.03M	147.99M	158.01M	171.32M	121.73M	179.05M	190.23M	209.58M	195.33M	162.36M	91.61M
Account Payables	414K	16K	31K	33K	331K	1.54M	117K	119K	276K	392K	425K	767K	824K	191K	894K	276K	275K
Deferred Revenue	19.25M	21.94M	24.86M	23.83M	20.59M	20.59M	16.41M	13.14M	5.83M	5.76M	8.62M	6.82M	5.66M	5.12M	19.99M	1.66M	570K
Short-Term Debt	4.66M	4.58M	4.51M	4.44M	4.37M	n/a	2.34M	2.92M	2.58M	2.5M	1.89M	7.21M	6.39M	4.77M	1.79M	1.56M	1.34M
Other Current Liabilities	7.46M	9.32M	7.48M	5.86M	6.31M	8.85M	5.07M	4.4M	5.5M	9.95M	13.84M	9.76M	8.3M	14.76M	10.07M	7.37M	7M
Total Current Liabilities	33.72M	38.9M	39.64M	37.28M	34.45M	34.23M	26.65M	22.98M	17.16M	21.11M	26.97M	27.14M	23.71M	27.6M	34.69M	12.37M	10.49M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	4.29M	2.89M	3.58M	3.9M	4.27M	4.77M	37.78M	38.37M	39.32M	17.51M	16.97M	16.51M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	50.63K	51.36K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.37M	n/a	n/a	n/a
Total Long-Term Liabilities	39.04M	40.5M	42.23M	47.92M	54.69M	62.34M	69.05M	73.51M	82.15M	85.1M	30.22M	64.94M	66.3M	68.75M	32.62M	32.44M	31.93M
Total Liabilities	72.75M	79.4M	81.87M	85.2M	89.14M	96.57M	95.69M	96.49M	99.31M	106.21M	57.19M	92.08M	90.02M	96.35M	67.31M	44.81M	42.43M
Total Debt	16.85M	17.22M	17.4M	19.19M	17.78M	19.75M	21.27M	21.53M	21.42M	21.97M	22.22M	60.93M	60.47M	60.37M	35.81M	35.38M	34.29M
Common Stock	4.31M	4.31M	3.37M	3.37M	3.37M	3.37M	3.37M	3.37M	3.38M	3.37M	2.99M	2.99M	3.01M	3M	3M	2.83M	2.19M
Retained Earnings	-436.23M	-427.16M	-418.02M	-410.55M	-408.57M	-401.18M	-395.73M	-391.93M	-384.93M	-380.68M	-370.34M	-345.62M	-333.87M	-317.77M	-300.19M	-285.4M	-269.88M
Comprehensive Income	979K	27.6M	716K	1.09M	26.61M	26M	1.29M	1M	27.15M	30.26M	34.06M	32.42M	31.71M	30.3M	27.62M	26.19M	25.08M
Shareholders Equity	78.94M	88.56M	24.98M	32.87M	34.85M	41.42M	46.34M	51.79M	59.01M	65.5M	64.92M	87.37M	100.83M	113.83M	128.61M	118.11M	49.74M
Total Investments	n/a	n/a	n/a	17.19M	17.02M	n/a	n/a	621K	621K	621K	621K	621K	621K	629K	713K	845K	621K